Balsalazide is more effective and better tolerated than mesalamine in the treatment of acute ulcerative colitis
- 1 January 1998
- journal article
- clinical trial
- Published by Elsevier in Gastroenterology
- Vol. 114 (1), 15-22
- https://doi.org/10.1016/s0016-5085(98)70627-4
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Zaldaride maleate, an intestinal calmodulin inhibitor, in the therapy of travelers' diarrheaGastroenterology, 1993
- Drug therapy of ulcerative colitis.British Journal of Clinical Pharmacology, 1992
- Drug management of ulcerative colitis.BMJ, 1992
- Some aspects of the epidemiology of ulcerative colitis.Gut, 1985
- Reversal with balsalazide of infertility caused by sulphsalazine.BMJ, 1984
- SulfasalazineDigestive Diseases and Sciences, 1983
- AN EXPERIMENT TO DETERMINE THE ACTIVE THERAPEUTIC MOIETY OF SULPHASALAZINEThe Lancet, 1977
- Adverse Reactions during Salicylazosulfapyridine Therapy and the Relation with Drug Metabolism and Acetylator PhenotypeNew England Journal of Medicine, 1973
- CONTROLLED TRIAL OF SULPHASALAZINE IN MAINTENANCE THERAPY FOR ULCERATIVE COLITISThe Lancet, 1965
- SULPHASALAZINE AND SALICYLAZOSULPHADIMIDINE IN ULCERATIVE COLITISThe Lancet, 1962